Navigation Links
NASA Nanotechnology-Based Biosensor Helps Detect Biohazards
Date:5/20/2008

MOFFETT FIELD, Calif., May 20 /PRNewswire-USNewswire/ -- NASA has developed a revolutionary nanotechnology-based biosensor that can detect trace amounts of specific bacteria, viruses and parasites. This biosensor will be used to help prevent the spread of potentially deadly biohazards in water, food and other contaminated sources.

NASA's Ames Research Center at Moffett Field in California licensed the biosensor technology to Early Warning Inc., Troy, N.Y. Under a Reimbursable Space Act Agreement, NASA and Early Warning jointly will develop biosensor enhancements. Initially, the biosensor will be configured to detect the presence of common and rare strains of microorganisms associated with water-borne illnesses and fatalities.

"The biosensor makes use of ultra-sensitive carbon nanotubes which can detect biohazards at very low levels," explained Meyya Meyyappan, chief scientist for exploration technology and former director of the Center for Nanotechnology at Ames. "When biohazards are present, the biosensor generates an electrical signal, which is used to determine the presence and concentration levels of specific micro-organisms in the sample. Because of their tiny size, millions of nanotubes can fit on a single biosensor chip."

Early Warning company officials say food and beverage companies, water agencies, industrial plants, hospitals and airlines could use the biosensor to prevent outbreaks of illnesses caused by pathogens - without needing a laboratory or technicians.

"Biohazard outbreaks from pathogens and infectious diseases occur every day in the U.S. and throughout the world," said Neil Gordon, president of Early Warning. "The key to preventing major outbreaks is frequent and comprehensive testing for each suspected pathogen, as most occurrences of pathogens are not detected until after people get sick or die. Biohazards can enter the water supply and food chain from a number of sources which are very difficult to uncover.
'/>"/>

SOURCE NASA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
2. Model is first to compare performance of biosensors
3. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
4. When proteins, antibodies and other biological molecules kiss, a new kind of biosensor can tell
5. Skin & Aging Article Finds Derma Sciences MEDIHONEY(TM) Helps to Promote Healing Where Antibiotics Fail
6. D-Ribose Helps Energy-Starved Hearts
7. Proteon Therapeutics Appoints Experienced Biopharmaceutical Executive, Gregory D. Phelps to its Board of Directors
8. NASA technology helps predict and prevent future pandemic outbreaks
9. Free White Paper Helps Biotech Laboratories Maintain a High Level of Infection Control
10. New Cardiology Software Helps Heart Centers Manage for Optimal Clinical Performance
11. Edison Innovation Fund Helps Tris Pharma Expand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research ... on the current state of the global Propanol market with a focus on the ... Eastman, Dow, Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem ...
(Date:7/30/2015)... , Inc. (NASDAQ: SNMX ), a leading company ... commercialize novel flavor ingredients for the food, beverage, and ... second quarter 2015. "Moving into the ... achieve our commercial and financial goals," stated John Poyhonen, ... our last quarterly earnings report, our two partners have ...
(Date:7/30/2015)...  Discovery Laboratories, Inc. (Nasdaq: DSCO ) ... $1.0M tranche under a previously awarded Phase II ... up to $3.0 million to support continued development ... potential medical countermeasure to mitigate acute and chronic/late-phase ... initial $1.0 million under this grant in October ...
(Date:7/29/2015)... July 30, 2015 Sanofi, ... publie ses résultats pour le premier semestre 2015. ... les résultats. Visionner l,interview vidéo et ... Au sommaire de l,interview :  ... Moteurs de croissance - Diabète ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3
... , SOUTH SAN FRANCISCO, Calif., Sept. 15 ... 320 evaluable events (patient deaths) have occurred in its pivotal Phase 3 ... in accordance with a Special Protocol Assessment (SPA) with the U.S. Food ... lung cancer (SCLC). , , "The ...
... , BASKING RIDGE, N.J., Sept. 15 ... antithrombotic aptamers with active control agents, announced today that ... BioPharm America Conference 2009 in San Francisco, CA at 3:15 ... will include an overview of the Company,s pipeline with emphasis ...
... KVISTGAARD, Denmark, September 15 Bavarian,Nordic A/S (OMX: BAVA) announced ... undisclosed EU country for the delivery of a small order for,IMVAMUNE(R). ... of,the contract is undisclosed. , This marks ... for the delivery of IMVAMUNE(R), and it demonstrates that there,exists a ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 2Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 3Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 4Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target 5Regado Biosciences to Present at the BioPharm America 2009 Conference on September 17, 2009 2Bavarian Nordic Has Signed Contract With an EU Country for the Delivery of IMVAMUNE(R) 2
(Date:7/9/2015)... July 9, 2015  Unchained Labs just can,t ... acquisition of Avid Nano. Avid Nano designs, develops ... systems.    Also today, Unchained Labs ... easiest to use protein sizing system. The pUNk ... protein,s hydrodynamic size, size distribution, aggregation population and ...
(Date:7/8/2015)... , July 8, 2015 Summary Pancreatic ... the fourth most fatal, with a mortality rate of ... prognosis of pancreatic cancer patients has highlighted a significant ... is not being met by the current market. ... of products with varying molecule types and mechanisms of ...
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... travel across a colony to actively seek males which ... local dominant males. These findings, published in this ... widespread in nature than previously believed and that such ... from the University of Cambridge and the British Antarctic ...
... in increasingly large areas. , The summer of 2006 ... records began in 1895, according to the National Climatic Data ... 40 percent of the country. , When Constance Brown ... struck by a major difference: people in Indiana don't think ...
... million research program at Iowa State University dedicated ... grant is part of ConocoPhillips' plan to create ... viable solutions to diversify America's energy sources. ... grant in 2007 to support Iowa State researchers, ...
Cached Biology News:Female Antarctic seals give cold shoulder to local males 2How trees manage water in arid environments 2How trees manage water in arid environments 3How trees manage water in arid environments 4ConocoPhillips establishes $22.5M biofuels research program at Iowa State 2ConocoPhillips establishes $22.5M biofuels research program at Iowa State 3
... Direct SPA Screening Assay, 5 ... that eliminate lengthy sample extraction procedures ... use).Range: 1.32-84.28 ng/ml (4-256 pmol/ml).Sensitivity: 0.65 ... 2-8 C. Category: Drug Screening & ...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.283. Immunogen: Fusion ... Specificity: Specific for ASIP/PAR-3 (atypical PKC ... This antigen is not related to ... Reactivity: Human Dog Xenopus (positive controls: ...
... synthase, cytoplasmic (C1-THF ... dehydrogenase (EC 1.5.1.5); ... 3.5.4.9); Formyltetrahydrofolate synthetase ... ...
Biology Products: